292 related articles for article (PubMed ID: 15838560)
1. Pharmacological treatment of congestive heart failure in Canada: a description of care in five provinces.
Cox JL; Ramer SA; Lee DS; Humphries K; Pilote L; Svenson L; Tu JV;
Can J Cardiol; 2005 Mar; 21(4):337-43. PubMed ID: 15838560
[TBL] [Abstract][Full Text] [Related]
2. Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000.
Pilote L; Beck CA; Karp I; Alter D; Austin P; Cox J; Humphries K; Jackevicius C; Richard H; Tu JV;
Can J Cardiol; 2004 Jan; 20(1):61-7. PubMed ID: 14968144
[TBL] [Abstract][Full Text] [Related]
3. Impact of restrictive prescription plans on heart failure medication use.
Thanassoulis G; Karp I; Humphries K; Tu JV; Eisenberg MJ; Pilote L
Circ Cardiovasc Qual Outcomes; 2009 Sep; 2(5):484-90. PubMed ID: 20031881
[TBL] [Abstract][Full Text] [Related]
4. Identifying opportunities to address the congestive heart failure burden: the Improving Cardiovascular Outcomes in Nova Scotia (ICONS) study.
Howlett JG; Johnstone DE; Sketris I; O'Reilly M; Horne GS; Cox JL;
Can J Cardiol; 2003 Mar; 19(4):439-44. PubMed ID: 12704493
[TBL] [Abstract][Full Text] [Related]
5. Economic implications of treatment guidelines for congestive heart failure.
Shibata MC; Nilsson C; Hervas-Malo M; Jacobs P; Tsuyuki RT
Can J Cardiol; 2005 Dec; 21(14):1301-6. PubMed ID: 16341301
[TBL] [Abstract][Full Text] [Related]
6. [Medical treatment of heart failure: an analysis of actual treatment practices in outpatients in Switzerland. The Swiss "IMPROVEMENT of HF" Group].
Muntwyler J; Follath F
Schweiz Med Wochenschr; 2000 Aug; 130(34):1192-8. PubMed ID: 11013922
[TBL] [Abstract][Full Text] [Related]
7. [Trends in pharmacological treatment of congestive heart failure].
Halawa B
Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
[TBL] [Abstract][Full Text] [Related]
8. Time trends in the use of beta-blockers and other pharmacotherapies in older adults with congestive heart failure.
Smith NL; Chan JD; Rea TD; Wiggins KL; Gottdiener JS; Lumley T; Psaty BM
Am Heart J; 2004 Oct; 148(4):710-7. PubMed ID: 15459605
[TBL] [Abstract][Full Text] [Related]
9. [Long-term trends in drug prescription for hospitalized patients with congestive heart failure. Influence of type of dysfunction].
Grigorian Shamagian L; Varela Román A; Virgos Lamela A; Rigueiro Veloso P; García Acuña JM; González-Juanatey JR
Rev Esp Cardiol; 2005 Apr; 58(4):381-8. PubMed ID: 15847735
[TBL] [Abstract][Full Text] [Related]
10. Regional outcomes of heart failure in Canada.
Lee DS; Johansen H; Gong Y; Hall RE; Tu JV; Cox JL;
Can J Cardiol; 2004 May; 20(6):599-607. PubMed ID: 15152289
[TBL] [Abstract][Full Text] [Related]
11. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
Gotsman I; Rubonivich S; Azaz-Livshits T
Isr Med Assoc J; 2008 Mar; 10(3):214-8. PubMed ID: 18494235
[TBL] [Abstract][Full Text] [Related]
12. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
[TBL] [Abstract][Full Text] [Related]
13. Adherence to guidelines for patients hospitalized with heart failure: a nationwide survey.
Jotkowitz AB; Porath A; Shotan A; Mittelman M; Grossman E; Zimlichman R; Lewis BS; Caspi A; Gottlieb S; Garty M;
Isr Med Assoc J; 2006 Dec; 8(12):875-9. PubMed ID: 17214110
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF.
Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
J Card Fail; 2007 Nov; 13(9):722-31. PubMed ID: 17996820
[TBL] [Abstract][Full Text] [Related]
15. The economic burden of congestive heart failure in a managed care population.
Xuan J; Duong PT; Russo PA; Lacey MJ; Wong B
Am J Manag Care; 2000 Jun; 6(6):693-700. PubMed ID: 10977478
[TBL] [Abstract][Full Text] [Related]
16. Current concepts in clinical therapeutics: congestive heart failure.
Klamerus KJ
Clin Pharm; 1986 Jun; 5(6):481-98. PubMed ID: 2872992
[TBL] [Abstract][Full Text] [Related]
17. Changes in adherence to evidence-based medications in the first year after initial hospitalization for heart failure: observational cohort study from 1994 to 2003.
Lamb DA; Eurich DT; McAlister FA; Tsuyuki RT; Semchuk WM; Wilson TW; Blackburn DF
Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):228-35. PubMed ID: 20031842
[TBL] [Abstract][Full Text] [Related]
18. Acute treatment of myocardial infarction in Canada 1999-2002.
Jackevicius CA; Alter D; Cox J; Daly P; Goodman S; Filate W; Newman A; Tu JV;
Can J Cardiol; 2005 Feb; 21(2):145-52. PubMed ID: 15729413
[TBL] [Abstract][Full Text] [Related]
19. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
Dulin BR; Krum H
Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological and pharmacological profile of congestive heart failure at Turkish academic hospitals.
Ergin A; Eryol NK; Unal S; Deliceo A; Topsakal R; Seyfeli E
Anadolu Kardiyol Derg; 2004 Mar; 4(1):32-8. PubMed ID: 15033616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
